4CPS-034 Deprescribing oral iron in elderly patients: experience from a nursing home associated with a third level hospital

J Ibanez-Caturla, P Pacheco, T Alonso-Domínguez… - 2022 - ejhp.bmj.com
Background and importance Oral iron is prescribed to elderly patients as the treatment for
episodes of iron deficiency anaemia. Inadequate follow-up and chronic prescription in …

CP-027 Efficacy and safety of ribavirin used for respiratory syncitial virus treatment in haematological patients

…, AM Rizo-Cerdá, T Alonso-Dominguez… - 2015 - ejhp.bmj.com
Background Ribavirin is a drug used to treat hepatitis, but it is also used (off-label) for the
treatment of respiratory syncytial virus (RSV) Purpose To evaluate the efficacy and safety of …

OHP-021 Utilisation analisys of lenalidomide in multiple myeloma

…, JC Titos-Arcos, T Alonso-Dominguez… - 2017 - ejhp.bmj.com
Background Lenalidomide is one of the main drugs for the treatment of multiple myeloma,
which has a high cost per patient. Purpose To describe and analyse the use of lenalidomide …

DI-060 Written patient information: analysing its quality

…, J Leon-Villa, I Gorostiza-Frias, T Alonso-Dominguez… - 2017 - ejhp.bmj.com
Background Health systems promote patient involvement in healthcare decisions. In order to
achieve this, patients need information and often this is supplied as written material so that …

PS-091 Detection of inappropriate prescriptions for elderly comorbid patients according to STOPP/START criteria

IS Martínez, NM Ramón, TA Dominguez… - European Journal of …, 2014 - ejhp.bmj.com
Background Inappropriate prescribing is highly prevalent in older people and has become a
global healthcare concern. Purpose To detect inappropriate prescriptions for patients …

CP-035 Low molecular weight heparins in renal impairment, obesity and elderly patients

…, AM Rizo-Cerdá, T Alonso-Dominguez… - 2015 - ejhp.bmj.com
Background Major bleeding complications with LMWH treatment have been reported both in
clinical studies and during post-marketing surveillance. Monitoring of anti-factor Xa activity is …

CP-134 Effectiveness and safety of treatment with eribulin in metastatic breast cancer

P Selvi-Sabater, JC Titos-Arcos… - European Journal of …, 2014 - ejhp.bmj.com
Background Eribulin is a new drug against metastatic breast cancer, one of the most
common cancers in women Purpose To study the effectiveness and safety of treatment with …

PKP-025 Effect of antiangiogenic treatments on biomarkers of oxidative stress in patients with age related macular degeneration

N Manresa-Ramón, J Mulero, P Zafrilla, M Losada… - 2016 - ejhp.bmj.com
Background Many authors have hypothesised that oxidative stress and exudative age
related macular degeneration (AMD) share common antecedents and proposed that novel …

CP-157 Analysis of the expenditure on the treatment of hepatitis C virus in 2015

ID Gorostiza-Frias, P Selvi-Sabater… - 2016 - ejhp.bmj.com
Background With the advent of new treatments for hepatitis C, we have achieved high cure
rates, although this entails a significant increase in drug spending. Purpose To describe and …

CP-026 Efficacy of triple therapy with protease inhibitors for the treatment of hepatitis C virus in clinical practice

…, N Manresa-Ramón, T Alonso-Dominguez… - 2015 - ejhp.bmj.com
Background Given the large number of new drugs for the treatment of hepatitis C virus
(HCV) and the high economic cost, it is important to decide which treatment is best suited to …